Immediate Impact

1 by Nobel laureates 2 from Science/Nature 56 standout
Sub-graph 1 of 24

Citing Papers

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
2 intermediate papers

Works of Chiaki Okuse being referenced

Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
2019
Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double‐blind, placebo‐controlled trial
2013

Author Peers

Author Last Decade Papers Cites
Chiaki Okuse 594 461 139 151 90 903
Spyridon P. Dourakis 620 413 184 152 60 1.0k
Koichi Takaguchi 917 767 139 130 57 1.1k
Soo Ryang Kim 488 464 136 60 85 858
Kotaro Matsunaga 606 392 236 147 54 876
Ching‐Yih Lin 434 390 230 105 42 854
Youn Jae Lee 607 484 120 91 56 926
Noritomo Shimada 757 595 98 75 58 909
June Sung Lee 556 493 214 113 58 888
Giuseppe Tarantino 595 462 414 152 72 1.0k
Shintaro Takaki 947 594 343 124 77 1.2k

All Works

Loading papers...

Rankless by CCL
2026